With the advent of mandatory quality reporting and increasing pressure on ASCs to cut costs, benchmarking is becoming all the more important. Here are 100 surgery center benchmarks, provided by VMG Health's Multi-Specialty Intellimarker 2011. All numbers are averages.
The Latest
Over time, surgery centers may need to grow from their original size and expand to accommodate additional case volume or specialties to stay competitive.
At the 19th Annual Ambulatory Surgery Centers Conference in Chicago, Kim Woodruff, vice president of corporate finances and compliance at Pinnacle III, will be giving a presentation titled "The Use of Social Media by ASCs and Practices."
The New Albany (Ind.) City Council is considering an amendment to city zoning for pain management clinics that would only allow clinics to open at least 500 feet from residential districts and 1,000 feet from other pain management clinics, according…
The American College of Radiology has published evidence-based guidelines developed by radiologists at Emory University Hospital in Atlanta and Georgia Health Sciences University in Augusta for the diagnosis and treatment of low back pain, according to a News Medical report.
56 Sports Medicine Practices to Know Here are 57 sports medicine practices to know. Click to continue » 12 Tactics for Spine Surgeons to Avoid Hospital Employment Spine surgeons, along with all specialists, are increasingly becoming employed by hospitals for…
Here are seven orthopedic surgeries for professional athletes.
DePuy Mitek, a developer and manufacturer of orthopedic sports medicine products and soft tissue repair devices, has launched its ENDURANCE Hip Solutions, a new system of instruments and devices developed for hip arthroscopy.
Stefan Prada, MD, is a board-certified orthopedic surgeon with Laser Spine Institute's Tampa, Fla., facility. Dr. Prada is a fellow of the American Academy of Orthopaedic Surgeons, and he has an interest in treating with minimally invasive, endoscopic procedures.
The Office of the Inspector General found Medicare Part D in 2009 paid $25 million for Schedule II drugs billed as refills, although federal law prohibits refilling these controlled substances.